Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Acute oral toxicity: OECD TG 401: LD50 2100 mg/kg bw.


Acute dermal toxicity: OECD TG 402: LD50 >2000 mg/kg bw.

Key value for chemical safety assessment

Acute toxicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
Value:
2 100 mg/kg bw

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
discriminating dose
Value:
2 000 mg/kg bw

Additional information

Acute oral toxicity


Using OECD TG 401, the acute median lethal oral dose (LD50) and their 95% confidence limits to rats of Neoproxen was 2.1 g/kg bodyweight (1.7 -2.7): males and females combined.


Acute dermal toxicity


The acute dermal toxicity of Neoproxen was determined in a GLP study according to OECD Guideline 402. There were no deaths or signs of systemic toxicity or dermal irritation. No abnormalities were noted at necropsy. The acute lethal dermal dose to rats of Neoproxen was found to be greater than 2.0 g/kg bodyweight.

Justification for classification or non-classification

The substance does not have to be classified for Acute oral and Acute dermal toxicity according to EU CLP (EC No. 1272/2008 and its amendments).